Literature DB >> 2256736

Disease activity and joint damage progression in early rheumatoid arthritis: relation to IgG, IgA, and IgM rheumatoid factor.

K B Eberhardt1, L Truedsson, H Pettersson, B Svensson, L Stigsson, J L Eberhardt, F A Wollheim.   

Abstract

The clinical and biochemical correlations with joint damage progression over two years in a consecutive group of 68 patients with rheumatoid arthritis with disease duration of less than two years are reported. Joint damage was assessed with Larsen's severity scale and a measure of change in progression rate constructed. Initial haemoglobin concentration, Ritchie index, and Waaler-Rose titre in combination accounted for one third of the variance in joint damage progression. Rheumatoid factor (RF) concentrations were followed with enzyme linked immunosorbent assays (ELISAs) for IgG RF, IgA RF, and IgM RF. The RF concentrations, except IgG RF, decreased with time; significant correlations between RFs and disease activity were few and barely clinically useful. After two years IgG RF correlated significantly with a radiological score if early non-erosive changes were omitted. All RFs tended to correlate better with this radiological score at all three observation points. Analyses of the change in progression rate indicated a time delay between development of radiographic changes and increase of IgG RF. These results suggest an indirect relation between RFs and joint damage. Clinical and biochemical improvements in early RA occur despite joint damage progression, and conventional markers have insufficient predictive value.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2256736      PMCID: PMC1004260          DOI: 10.1136/ard.49.11.906

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  25 in total

1.  DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

2.  Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.

Authors:  A Larsen; K Dale; M Eek
Journal:  Acta Radiol Diagn (Stockh)       Date:  1977-07

3.  Radiographic changes in early rheumatoid disease.

Authors:  A Brook; M Corbett
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

4.  Assessment methods of disease activity in juvenile rheumatoid arthritis--evaluated in a prednisolone/placebo double-blind study.

Authors:  T K Kvien; H M Høyeraal; B Sandstad
Journal:  J Rheumatol       Date:  1982 Sep-Oct       Impact factor: 4.666

5.  Interobserver variation in the evaluation of radiologic changes of rheumatoid arthritis.

Authors:  A Larsen; J Edgren; E Harju; L Laasonen; T Reitamo
Journal:  Scand J Rheumatol       Date:  1979       Impact factor: 3.641

6.  Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.

Authors:  G Borg; E Allander; B Lund; E Berg; U Brodin; H Pettersson; L Trang
Journal:  J Rheumatol       Date:  1988-12       Impact factor: 4.666

7.  International reference preparation of rheumatoid arthritis serum.

Authors:  S G Anderson; M W Bentzon; V Houba; P Krag
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

8.  Isotype-specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis.

Authors:  A Tarkowski; L A Nilsson
Journal:  J Clin Lab Immunol       Date:  1983-11

9.  Relationship between the articular manifestations of rheumatoid arthritis and circulating immune complexes detected by three methods and specific classes of rheumatoid factors.

Authors:  J Lessard; E Nunnery; F Cecere; S McDuffy; R M Pope
Journal:  J Rheumatol       Date:  1983-06       Impact factor: 4.666

10.  Measurement of patient outcome in arthritis.

Authors:  J F Fries; P Spitz; R G Kraines; H R Holman
Journal:  Arthritis Rheum       Date:  1980-02
View more
  17 in total

1.  Rheumatoid factor isotypes in mixed connective tissue disease.

Authors:  Yoshihiro Mimura; Hironobu Ihn; Masatoshi Jinnin; Yoshihide Asano; Kenichi Yamane; Kunihiko Tamaki
Journal:  Clin Rheumatol       Date:  2006-01-04       Impact factor: 2.980

2.  A human monoclonal IgA rheumatoid factor using the VkIV light chain gene.

Authors:  R Mierau; A Gause; R Küppers; M Michels; R A Mageed; R Jefferis; E Genth
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

Review 3.  Is measurement of rheumatoid factor isotypes clinically useful?

Authors:  T Jónsson; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

4.  Early rheumatoid arthritis--onset, course, and outcome over 2 years.

Authors:  K B Eberhardt; L C Rydgren; H Pettersson; F A Wollheim
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

5.  Radiographic estimation in seropositive and seronegative rheumatoid arthritis.

Authors:  Vjollca Sahatçiu-Meka; Sylejman Rexhepi; Suzana Manxhuka-Kërliu; Mjellma Rexhepi
Journal:  Bosn J Basic Med Sci       Date:  2011-08       Impact factor: 3.363

6.  Radiological progression in rheumatoid arthritis: how many patients are required in a treatment trial to test disease modification?

Authors:  J T Sharp; F Wolfe; M Corbett; H Isomaki; D M Mitchell; D E Furst; J Sibley; M Shipley
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

7.  Prognostic laboratory markers of joint damage in rheumatoid arthritis.

Authors:  E Lindqvist; K Eberhardt; K Bendtzen; D Heinegård; T Saxne
Journal:  Ann Rheum Dis       Date:  2004-09-30       Impact factor: 19.103

8.  Rheumatoid factor measured by fluoroimmunoassay: a responsive measure of rheumatoid arthritis disease activity that is associated with joint damage.

Authors:  E Knijff-Dutmer; W Drossaers-Bakker; A Verhoeven; G van der Sluijs Veer; M Boers; S van der Linden; M van de Laar
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

9.  Synovial tissue macrophages and joint erosion in rheumatoid arthritis.

Authors:  G Yanni; A Whelan; C Feighery; B Bresnihan
Journal:  Ann Rheum Dis       Date:  1994-01       Impact factor: 19.103

10.  Does practice mirror the evidence base in the treatment of rheumatoid arthritis?

Authors:  Iain McInnes
Journal:  Clin Rheumatol       Date:  2009-05-13       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.